A new blood test developed by MIT researchers can distinguish between the Zika and dengue viruses, reports Andrew Joseph for STAT. “Being able to distinguish the four serotypes is very important for epidemiology purposes and to know what viruses are circulating in an environment,” explains Prof. Lee Gehrke.
Prof. Lee Gehrke speaks with WBUR’s Carey Goldberg about a new paper-based diagnostic that can detect the Zika virus. “Our technology for screening large numbers of antibodies against a panel of closely related viral proteins has allowed us to specifically identify antibodies that recognize only one of the viral antigens, and that gives us a great deal of specificity.”
MIT researchers have developed a new test that can identify dengue and the Zika virus quickly and cheaply, reports Sophie Hares for Reuters. “Knowing whether these tests are positive or negative is very important for designing the course of clinical care,” explains Prof. Lee Gehrke. “It simplifies the decision tree and, we believe, leads to improved patient care.”
CSAIL researchers have developed a new shape-shifting robot that can change outfits in order to perform different tasks, reports Timothy Revell for New Scientist. “In the future, we imagine robots like this could become mini surgeons, squished into a pill that you swallow,” explains Prof. Daniela Rus.
A new study co-authored by research affiliate Judah Cohen shows that the extreme winters of the past few years can be attributed to the warming Arctic, writes Kendra Pierre-Louis for Popular Science. While most associate warmer temperatures with climate change, “a warming climate sends ripples of change across the entire climate system, which sometimes means some very cold winters.”
UPI reporter Brooks Hays writes that MIT researchers have developed a set of mathematical equations to help identify patterns that can lead to extreme events. “If researchers can anticipate the warning signs of extreme events, mitigation efforts could be instigated sooner, potentially preventing loss of life and property,” Hays explains.
Prof. Feng Zhang has been awarded the Lemelson-MIT Prize, reports Sharon Begley for STAT. Zhang was honored for his, “track record of innovations and of coming up with big ideas that change fields,” explains Prof. Michael Cima, faculty director of the award. “Zhang is one of those individuals who move through groups of talented people sparking new ideas.”
Prof. Regina Barzilay, a breast cancer survivor, participated in a Washington Post Live discussion about “her own experience with the disease and how she uses data and machine learning to advance detection and treatment.”
Bryan Marquard of The Boston Globe writes about the legacy of Paul Gray, the 14th president of MIT, who died at 85 and was known for his efforts to increase diversity at MIT. Gray was a “transformative administrator who enrolled at MIT as an electrical engineering student in 1950 and retired in 1997 as chairman of the MIT Corporation, the institute’s governing body,” writes Marquard.
Boston Globe reporter Alyssa Meyers spotlights an MIT course that exposes students to what it is like to live with different disabilities. Based off their experience, students develop, “an assistive technology for a client, where the clients are individuals in the community who have proposed project ideas to the class,” explains senior lecturer Julie Greenberg.
BBC News reporter James Gallagher writes that MIT researchers have developed a new technology that could eventually enable doctors to administer multiple vaccines in one shot.
Guardian reporter Nicola Davis writes that MIT researchers have developed a new approach that could be used to deliver multiple vaccines in one injection. Davis explains that the technique could prove useful in developing countries, “potentially allowing all childhood vaccines and their boosters to be given in one shot.”
MIT researchers have developed a new way of creating drug-carrying particles that could allow multiple doses of a vaccine to be delivered over an extended period of time, reports Matt Reynolds for New Scientist. “The technology could eventually be used to create ‘omni-vaccines’ that protect against a whole host of diseases in one shot.”
Boston Magazine reporter Rowan Walrath writes that MIT researchers have developed a new technique that could be used to deliver multi-drug vaccines. The researchers developed a new method for “designing customizable, three-dimensional microparticles that resemble minuscule coffee cups. Each cup…contains a drug or vaccine ‘library’ that can be released at multiple points over an extended period of time.”
Bloomberg News reporters Tim Loh and Patrick Martin feature Prof. Jeffrey Grossman’s work turning coal into thin strips of durable film that can conduct electricity. “You can get them up to like 300 Celsius (572 degrees Fahrenheit),” Grossman explains. “That is by far much, much better than other kinds of thin-film heaters.’’